Saudi Arabia is taking significant strides in biotechnology with Crown Prince Mohammed bin Salman’s recent announcement of the National Biotechnology Strategy.
Arab News reports this strategic move aligns with the ambitious Vision 2030 goals, emphasising the Kingdom’s commitment to diversify its economy and invest in cutting-edge sectors.
The newly unveiled strategy focuses on biotech-related fields, including biomanufacturing, genomics, food optimisation, and vaccine industries.
Localising vaccine manufacturing and enhancing the overall health of Saudi citizens are among the primary objectives.
However, the strategy goes beyond healthcare, aiming to address environmental concerns, achieve food and water security, and position Saudi Arabia as a global leader in biotechnology.
Rabia Yasmeen, a senior consultant at Euromonitor International, sees biotechnology as a crucial element for economic diversification, emphasising its potential to treat diseases and improve the quality of life.
ALSO SEE: PICTURES: Habibi, Can I peel your almonds? Saudi’s winter nutty delight
The strategy also targets food self-sufficiency, recognizing the importance of enhancing agricultural productivity to reduce import dependency.
Incorporating genomics into Saudi Arabia’s biotech initiatives is highlighted as a potential game-changer.
Genomics and precision medicine are anticipated to address challenges in the healthcare landscape, including high obesity levels and the development of medicines tailored to the Kingdom’s unique genome profile.
Jassim Al-Shammari, founder of the Saudi Industrialists and Exporters Platform, sees the National Biotechnology Strategy as pivotal for the Kingdom’s economic development.
He envisions a strengthened pharmaceutical industry, reduced dependence on imports, increased self-sufficiency, and advancements in digital transformation and technological innovation within pharmaceutical industries.
The strategy is seen as an economic boost and a means to address key issues such as food security and healthcare challenges.
The Kingdom’s investments in renowned academic institutions, research funding, and biotech infrastructure demonstrate a comprehensive approach to building a thriving biotech sector.
Early projections indicate the strategy will create thousands of job opportunities and contribute significantly to non-oil GDP.
It is expected to play a vital role in Saudi Arabia’s economic diversification journey, aligning with the accelerated growth in non-oil revenues experienced since the launch of Vision 2030.
Biotech startups are already recogniSing Saudi Arabia as a promising hub for funding, reflecting the growing relevance of the Kingdom in the global biotech ecosystem.
The strategy positions Saudi Arabia as a leader in healthcare and a key player in materials, manufacturing, agriculture, and other sectors crucial for the region’s future.
As the Kingdom pushes forward with its biotechnology ambitions, it aims to lead the global energy story by advancing biofuels, renewable energy sources, and greener alternatives, signalling a transformative chapter in Saudi Arabia’s technological diversification journey.
ALSO READ: BRICS Technology: Bioplastics explored as an alternative
